Gastric Cancer News

Herceptin Improves Outcome of HER2-positive Stomach Cancer (October 3, 2009)

According to the results of a Phase III clinical trial, treatment with the targeted therapy Herceptin® (trastuzumab) improves survival among patients with HER2-positive, advanced and inoperable stomach cancer. These results were presented at a major... Continue Reading

Aspirin May Reduce Risk of Stomach Cancer (August 28, 2009)

Regular aspirin use may reduce the risk of distal stomach cancer (cancer in the lower part of the stomach). These results were published in the American Journal of Epidemiology. Cancer of the stomach is called gastric cancer. Gastric adenocarcinoma is... Continue Reading

Herceptin® Improves Survival with HER2-positive Gastric Cancer (June 2, 2009)

Herceptin® Improves Survival with HER2-positive Gastric Cancer According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy... Continue Reading

Gleevec® Reduces Risk of Recurrence After Surgery for Localized Gastrointestinal Stromal Tumors (March 31, 2009)

Among patients with localized gastrointestinal stromal tumors, adjuvant (post-surgery) treatment with the targeted therapy Gleevec® (imatinib mesylate) reduces the risk of cancer recurrence. These results were published in The Lancet. Gastrointestinal... Continue Reading

Herceptin® Improves Survival with HER2-positive Stomach Cancer (March 31, 2009)

Gastric Cancer Patients: Understanding Peripheral Neuropathy (February 5, 2009)

If you’ve received chemotherapy as part of your gastric cancer treatment, one of the side effects you may experience is numbness and tingling in you extremities, also known as peripheral neuropathy. The following guidelines explain how to recognize... Continue Reading

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (August 4, 2008)

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer Among patients diagnosed with gastric (stomach) cancer, a combination of antibiotics against the bacterium Helicobacter pylori (H. pylori) significantly reduces the risk... Continue Reading

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (August 4, 2008)

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (July 23, 2008)

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. These results were recently published in... Continue Reading

No Treatment Advantage with Cisplatin for Gastric Cancer (April 2, 2008)

No Treatment Advantage with Cisplatin for Gastric Cancer Results from a recent study indicate that the addition of the drug cisplatin (Platinol®) did not improve response rates, survival rates, or progression-free survival for patients with gatric cancer.... Continue Reading